Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.

presentation

Jul 4, 2024

Groundbreaking Research in Ovarian Cancer

Sarah Nersesian, winner of the prestigious 2024 Anita Unruh Prize, prove the value of investing in research trainees.

presentation

Apr 10, 2024

Apr 10, 2024

OCC’s interview with Stephanie Gill

Stephanie Gill, obstetrics and gynaecology resident at Memorial University of Newfoundland.

presentation

Apr 7, 2024

Apr 7, 2024

Ovarian cancer prevention can save lives now

Ovarian Cancer Canada establishes Ovarian Cancer Prevention Task Force to help decrease incidence of the disease

presentation

Dec 14, 2023

Ovarian Cancer Canada applauds the government’s commitment to women’s health

We are grateful and proud to announce that Ovarian Cancer Canada (OCC) is one of the recipients of the Government of Canada’s Strategic Science Fund (SSF).

presentation

Dec 4, 2023

A strategic partnership of $1.2M for ovarian cancer treatments

Ovarian Cancer Canada (OCC) and the Cancer Research Society (CRS) jointly announce the launch of the "Bridging the Gap for Ovarian Cancer Treatments Grants Competition".

presentation

Mar 15, 2023

Mar 15, 2023

Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources

Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer (Q-CROC) are teaming up to optimize the support available to women affected by ovarian cancer in Quebec.

presentation

Feb 15, 2023

Advocacy in action: Making game-changing PARP Inhibitors accessible for women in Prince Edward Island

Women living in Prince Edward Island (PEI) now have access to precision treatments for ovarian cancer, thanks to Ovarian Cancer Canada’s advocacy efforts.

presentation

Feb 8, 2023

Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world

Every 5 hours, we lose someone we love to ovarian cancer in Canada. Ovarian cancer is the most fatal women’s cancer and sadly, one in two diagnosed do not live to see another five years.

presentation

Dec 16, 2022

Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative

Two funded clinical trials, though different in their approach and focus, share a dedication to exploring innovative treatment pathways and a made-in-Canada pedigree.

Connect

with us

Have a question or want to speak with a team member?

Get in touch